Skip to main content

Table 1 Clinical characteristics of 145 patients

From: Prognostic impact of clinicopathologic parameters in stage II/III breast cancer treated with neoadjuvant docetaxel and doxorubicin chemotherapy: paradoxical features of the triple negative breast cancer

Characteristics

No. of Pt (%)

Median age (range)

45 (range 25–69)

   Age < 50

102 (70.3)

   Age ≥ 50

43 (29.7)

Performance status

 

   ECOG 0–1

139 (95.9)

   ECOG 2

6 (4.1)

Pathologic characteristics

 

   Invasive ductal carcinoma

137 (94.5)

   Others

8 (5.5)

Initial clinical stage

 

   IIA

2 (1.4)

   IIB

21 (14.5)

   IIIA

70 (48.3)

   IIIB

34 (23.4)

   IIIC

18 (12.4)

Median tumor size

5.0 cm (range 1.2–12.0 cm)

Inflammatory breast cancer

 

   Yes

18 (12.4)

   No

127 (87.6)

Type of surgery

 

   Breast conserving

52 (35.9)

   Mastectomy

93 (64.1)

Adjuvant hormonal therapy

 

   Yes

63 (43.4)

   No

82 (56.6)

Radiation therapy

 

   Yes

128 (88.3)

   No

17 (11.7)

  1. ECOG, Eastern Cooperative Oncology Group.